Biotricity is trading 7.3% up at $0.07 on September 29, 2026, with no company-specific catalyst confirmed.
- The company’s news archive lists February 11, 2026, as its latest press release; no September 29 announcement is shown.
- The broader market is mixed: the S&P 500 and Nasdaq are slightly higher, while the Dow is slightly lower.